<DOC>
	<DOCNO>NCT02628509</DOCNO>
	<brief_summary>The WITAVI study design explore kinetic associate outcome Von Willebrand Factor-multimerizaton defect associate device cardiovascular disease .</brief_summary>
	<brief_title>Von Willebrand Factor As Biological Sensor Blood Flow Percutaneous Cardiac Procedure</brief_title>
	<detailed_description>This study design understand Von Willebrand Factor ( VWF ) abnormalities observe association implantation different device cardiovascular disease ( percutaneous valve replacement circulatory support device ) . The main objective study describe time-course VWF abnormality onset/offset implantation device cardiovascular disease . Adult patient &gt; 18 year need CF-LVAD trans-aortic valve implantation include cohort ; Blood sample obtain procedure</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Adult patient &gt; 18 year need mechanical circulatory support due advance heart failure undergo transaorticvalvereplacement treat aortic stenosis . Informed consent patient support person case disability baseline ( patient intubate ventilate ) Patient know severe bleed disorder Patient refusal environment Minor patient Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Acquired Von Willebrand</keyword>
	<keyword>Trans aortic valve replacement</keyword>
	<keyword>mechanical circulatory support</keyword>
</DOC>